FDA Clearance Tracker · P990025
NAVI-STAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
Last checked: Nov 20, 2026Latest source record: Jun 15, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Jun 15, 2000
Approved
Time to decision
388 days
Received May 24, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class II
The decision
- FDA number
- P990025
- Device name
- NAVI-STAR DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- May 24, 1999
- Decided
- Jun 15, 2000
- Decision
- Approved
- Supplements
- 72 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1220
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE NAVI-STAR(R) DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER. THE NAVI-STAR DIAGNOSTIC/ABLATION CATHETER, AND RELATED ACCESSORY DEVICES ARE INDICATED FOR CATHETER-BASED ATRIAL AND VENTRICULAR CARDIAC MAPPING, AND WHEN USED WITH A COMPATIBLE RADIO FREQUENCY GENERATOR IN ADULTS AND CHILDREN 4 YEARS OF AGE AND OLDER FOR:* INTERRUPTION OF ACCESSORY ATRIOVENTRICULAR (AV) CONDUCTION PATHWAYS ASSOCIATED WITH TACHYCARDIA; INCLUDING PERSISTEND JUNCTIONAL RE-ENTRANT TACHYCARDIA (PJRT) ...
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DRF. The earliest in FDA's data is K770341, decided Feb 28, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
K252972 · Decided Feb 20, 2026 · 156 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
K254085 · Decided Jan 18, 2026 · 31 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.